Yield10 Bioscience logo
Yield10 Bioscience YTEN

Quarterly report 2024-Q2
added 08-14-2024

report update icon

Yield10 Bioscience Cash Flow 2011-2025 | YTEN

Annual Cash Flow Yield10 Bioscience

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Operating Cash Flow

-10.1 M -11.4 M -9.25 M -8.66 M -8.65 M -8.75 M -8.2 M - -21.9 M -24.5 M -26.6 M -31.7 M -

Depreciation & Amortization

290 K 263 K 220 K 182 K 203 K 196 K 206 K 515 K 265 K 507 K 928 K 1.3 M 1.51 M

Accounts Payables

1.2 M 109 K 83 K 60 K 279 K 117 K 76 K 56 K 120 K 333 K 579 K 1.23 M 512 K

Accounts Receivables

- - 164 K 86 K 72 K 94 K 54 K 66 K 238 K 45 K 997 K 839 K 146 K

Total Inventories

- - - - - - - - 379 K 586 K 4.07 M 3.2 M -

All numbers in USD currency

Quarterly Cash Flow Yield10 Bioscience

2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Operating Cash Flow

- -903 K - - - -2.67 M - -8.34 M -5.64 M -3.1 M - -6.77 M -4.78 M -2.64 M - -6.67 M -4.61 M -2.29 M - -5.44 M -4.08 M -2.3 M - -6.73 M -4.89 M -3.03 M - -6.31 M -4.29 M -2.43 M - -12 M -7.62 M -6.53 M - -16.4 M -12.1 M -6.66 M - -18.6 M -13.8 M -8.96 M - -20.2 M - - - - - - - - - -

Depreciation & Amortization

- 66 K - - - 69 K - 197 K 128 K 59 K - 165 K 108 K 54 K - 137 K 91 K 48 K - 150 K 100 K 50 K - 146 K 96 K 47 K - 158 K 106 K 53 K - 458 K 272 K 122 K - 167 K 100 K 55 K - 430 K 333 K 191 K - 737 K 531 K 295 K - 1.03 M 718 K 379 K - 1.13 M 770 K 384 K

Accounts Payables

2.37 M 1.65 M 1.2 M 381 K 467 K 495 K 109 K 104 K 24 K 24 K 83 K 45 K 101 K 111 K 60 K 60 K 60 K 60 K 279 K 279 K 279 K 279 K 117 K 117 K 117 K 117 K 76 K 76 K 76 K 76 K 56 K 56 K 56 K 56 K 120 K 120 K 120 K 120 K 333 K 333 K 333 K 333 K 579 K 579 K 579 K 579 K 1.23 M 1.23 M 1.23 M 1.23 M 512 K 512 K 512 K 512 K

Accounts Receivables

- - - - - - - 37 K 35 K 124 K 164 K 24 K 76 K 39 K 86 K 86 K 86 K 86 K 72 K 72 K 72 K 72 K 94 K 94 K 94 K 94 K 54 K 54 K 54 K 54 K 66 K 66 K 66 K 66 K 238 K 238 K 238 K 238 K 45 K 45 K 45 K 45 K 997 K 997 K 997 K 997 K 839 K 839 K 839 K 839 K 146 K 146 K 146 K 146 K

Total Inventories

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 396 K 420 K 51 K 51 K 379 K 379 K 586 K 586 K 586 K 586 K 1.92 M 1.92 M 4.07 M 4.07 M 3.2 M 3.2 M 3.2 M 3.2 M - - - -

All numbers in USD currency

Cash Flow Statement is one of the three key financial reports of the company Yield10 Bioscience, reflecting the actual cash inflows and outflows over a certain period. Unlike the income statement, which shows revenues and expenses on an accrual basis, the cash flow statement focuses on real cash flows — how much cash actually came into the company and how much was spent.

Main Sections of the Cash Flow Statement
  • Operating Activities
    This section reflects cash flows related to the company’s core operations: receipts from sales of goods and services, payments to suppliers, employee salaries, taxes, and other operating expenses. Positive cash flow from operating activities indicates the viability of the business and its ability to generate cash.
  • Investing Activities
    Shows cash movements related to the purchase and sale of long-term assets such as real estate, equipment, and investments in other companies. Negative cash flow here often indicates investments in growth, which can be a positive sign.
  • Financing Activities
    Reflects the inflow and outflow of cash related to raising and repaying capital: issuing shares, loans, dividend payments, and loan repayments. This section shows how the company finances its activities and distributes profits.

The cash flow statement is important for investors because it allows them to assess the company’s real liquidity, showing whether it has enough cash to cover current obligations and investments — this is critical for financial stability. Additionally, it helps analyze the quality of earnings, since profits reported in the income statement can be "paper" profits and may not reflect actual cash inflows; the cash flow statement reveals this difference. The presence of free cash is also crucial for evaluating the company’s ability to finance growth and pay dividends, which is important for investors. Attention should also be paid to prolonged negative cash flows from operating activities, as this may serve as a warning sign of potential problems with the core business.

Cash flow statements of other stocks in the Agricultural inputs sector

Issuer Price % 24h Market Cap Country
Bioceres Crop Solutions Corp. Bioceres Crop Solutions Corp.
BIOX
$ 1.59 0.63 % $ 435 M argentinaArgentina
China Green Agriculture China Green Agriculture
CGA
- 0.51 % $ 27.6 M chinaChina
ICL Group Ltd ICL Group Ltd
ICL
$ 5.07 0.3 % $ 7.83 B israelIsrael
Marrone Bio Innovations Marrone Bio Innovations
MBII
- -5.9 % $ 180 M usaUSA
CF Industries Holdings CF Industries Holdings
CF
$ 78.88 0.28 % $ 14.2 B usaUSA
FMC Corporation FMC Corporation
FMC
$ 13.92 1.9 % $ 1.74 B usaUSA
Corteva Corteva
CTVA
$ 65.85 -0.29 % $ 45.7 B usaUSA
Arcadia Biosciences Arcadia Biosciences
RKDA
$ 3.64 -1.62 % $ 4.5 M usaUSA
American Vanguard Corporation American Vanguard Corporation
AVD
$ 4.29 -3.27 % $ 120 M usaUSA
Intrepid Potash Intrepid Potash
IPI
$ 27.3 -0.84 % $ 352 M usaUSA
The Mosaic Company The Mosaic Company
MOS
$ 26.23 4.13 % $ 8.39 B usaUSA
Nutrien Ltd. Nutrien Ltd.
NTR
$ 62.61 2.64 % $ 34.8 B canadaCanada
Origin Agritech Limited Origin Agritech Limited
SEED
$ 1.44 -3.99 % $ 8.09 M chinaChina
CVR Partners, LP CVR Partners, LP
UAN
$ 95.2 0.37 % $ 1.01 B usaUSA
The Scotts Miracle-Gro Company The Scotts Miracle-Gro Company
SMG
$ 57.45 3.7 % $ 3.31 B usaUSA